Annual Reports

Quarterly Reports


  • 8-K (Mar 14, 2018)
  • 8-K (Mar 12, 2018)
  • 8-K (Feb 16, 2018)
  • 8-K (Jan 22, 2018)
  • 8-K (Jan 8, 2018)
  • 8-K (Jan 5, 2018)


Arena Pharmaceuticals 8-K 2008

Documents found in this filing:

  1. 8-K
  2. Ex-99.1
  3. Ex-99.1





Washington, D.C. 20549





Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):  October 28, 2008


Arena Pharmaceuticals, Inc.

(Exact name of registrant as specified in its charter)







(State or other jurisdiction


(Commission File Number)


(I.R.S. Employer

of incorporation)




Identification No.)


6166 Nancy Ridge Drive, San Diego, California 92121

(Address of principal executive offices)   (Zip Code)



(Registrant’s telephone number, including area code)



(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





In this report, “Arena Pharmaceuticals,” “Arena,” “we,” “us” and “our” refer to Arena Pharmaceuticals, Inc. and its wholly owned subsidiaries, unless the context otherwise provides.


Item 2.02 Results of Operations and Financial Condition.


On October 30, 2008, we issued a press release reporting our financial results for the third quarter ended September 30, 2008. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.


Item 8.01 Other Events.


On October 28, 2008, we received redemption notices from the two holders of our Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock (collectively, the “Series B Preferred”). Pursuant to their rights under the Certificate of Designations applicable to the Series B Preferred, such holders elected to have all of their outstanding shares of Series B Preferred redeemed by us on November 13, 2008. The redemption price is equal to the stated value of such shares plus all accrued but unpaid dividends thereon to the date of payment, or an aggregate of approximately $55.8 million. We elected to redeem all of such shares in cash.


Item 9.01 Financial Statements and Exhibits.


(d)                                Exhibits.


99.1                          Press release issued October 30, 2008, reporting financial results for the third quarter ended September 30, 2008




Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: October 30, 2008

Arena Pharmaceuticals, Inc.







/s/ Jack Lief



Jack Lief



President and Chief Executive Officer






Exhibit No.








Press release issued October 30, 2008, reporting financial results for the third quarter ended September 30, 2008



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki